Provided by Tiger Trade Technology Pte. Ltd.

ZHAOKE OPHTH-B

2.520
+0.0351.41%
Volume:166.10K
Turnover:415.16K
Market Cap:1.38B
PE:-5.64
High:2.520
Open:2.470
Low:2.470
Close:2.485
52wk High:4.210
52wk Low:2.380
Shares:549.00M
HK Float Shares:549.00M
Volume Ratio:0.58
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.447
ROE:-13.89%
ROA:-8.82%
PB:0.85
PE(LYR):-5.64
PS:33.80

Loading ...

Zhaoke Ophthalmology - Yuvezzitm Approved by Macau Pharmaceutical Administration Bureau for Presbyopia Treatment

THOMSON REUTERS
·
Jul 20

Zhaoke Ophthalmology Says Macau Regulator Approves Presbyopia Eye Drop Yuvezzi

Reuters
·
Jul 20

Lee's Pharmaceutical Enters Exclusive Licensing and Supply Deal for Interferon Alpha-2b Outside Greater China

Stock News
·
Jul 17

Key Corporate Updates from Hong Kong-Listed Companies: Strategic Alliances, Financial Results, and Regulatory Milestones

Stock News
·
Jul 14

Zhaoke Ophthalmology acquires global rights to pediatric-myopia drug NVK002

Bulletin Express
·
Jul 13

Zhaoke Ophthalmology-B Secures Worldwide Rights for NVK002 Atropine Sulfate Eye Drops

Stock News
·
Jul 13

Zhaoke Ophthalmology Ltd - Entered into Definitive Agreement for Acquisition of Global Rights to Nvk002

THOMSON REUTERS
·
Jul 13

Zhaoke Ophthalmology - Grants Perpetual Royalty-free Exclusive U.S. Nvk002 License to Nevakar Pharmaceuticals

THOMSON REUTERS
·
Jul 13

Zhaoke Ophthalmology: Cumulative Share Buybacks Reach 1.72 Million Shares, Representing 0.31% of Issued Capital

Bulletin Express
·
Jul 09

Zhaoke Ophthalmology-B (06622) Repurchases 8,500 Shares for HK$22,100 on July 9

Stock News
·
Jul 09

Zhaoke Ophthalmology-B's Innovative Presbyopia Treatment YUVEZZI™ Approved for Import and Use at Boao Super Hospital

Stock News
·
Jul 07

Zhaoke Ophthalmology Gains Hainan Approval for YUVEZZI™, China’s First Innovative Presbyopia Therapy

Bulletin Express
·
Jul 07

Zhaoke Ophthalmology - Yuvezzitm Approved for Use at Boao Super Hospital as Clinically Urgent Imported Drug

THOMSON REUTERS
·
Jul 07

Zhaoke Ophthalmology Ltd - Approval from Hainan Provincial Medical Products Administration

THOMSON REUTERS
·
Jul 07

Zhaoke Ophthalmology Files HKEX Next-day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Jul 07

Zhaoke Ophthalmology Buys Back 7,500 Shares on 3 July; Cumulative 1.70 Million Shares Repurchased Since Mandate

Bulletin Express
·
Jul 03

Zhaoke Ophthalmology repurchases 39,500 shares; total buybacks reach 1.69 million, 3.08% of 2026 mandate utilised

Bulletin Express
·
Jul 03

Zhaoke Ophthalmology Files HKEX Next-day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Jul 03

Zhaoke Ophthalmology buys back 1.65 million shares in June, equal to 0.30% of share capital

Bulletin Express
·
Jun 30

Zhaoke Ophthalmology-B Allocates Approximately HK$229,400 for Share Repurchase on June 30

Stock News
·
Jun 30